AI assistant
Sending…
Genscript Biotech Corporation — Regulatory Filings 2018
Sep 28, 2018
49993_rns_2018-09-28_30d228fd-cd6d-41d7-8aea-07e0332234d6.htm
Regulatory Filings
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}
Listed Company Information
| Listed Company Information |
| EXCHANGE NOTICE - RESUMPTION OF TRADING Trading in the shares (stock code: 01548) of Genscript Biotech Corporation (the 'Company') will be resumed at 9:00 a.m. today (28/9/2018). Accordingly, all structured products relating to the Company will also be resumed for trading at the same time. |
More from Genscript Biotech Corporation
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 6
Earnings Release
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Environmental & Social Information
2026
Apr 13
Regulatory Filings
2026
Apr 13
Governance Information
2026
Apr 10
Share Issue/Capital Change
2026
Apr 2